首页|云浮市血液筛查反应性献血者归队分析

云浮市血液筛查反应性献血者归队分析

扫码查看
目的 分析云浮市血液筛查反应性献血者归队情况,为持续改进献血者归队管理提供依据。方法 乙型肝炎病毒表面抗原(HBsAg)、丙型肝炎病毒抗体(HCVAb)单试剂反应性献血者自屏蔽期满6个月后,或人类免疫缺陷病毒抗体(HIVAb)、梅毒螺旋体抗体(抗TP)单试剂反应性献血者自屏蔽期满3个月后,根据自愿原则向屏蔽单位提出归队申请,由屏蔽单位采样后进行两次双试剂酶联免疫吸附法(ELISA)、单人份核酸检测合格后,允许归队。结果 2018年1月至2022年12月,共101例献血者符合申请归队,按申请归队原因分类,HBsAg 占 8。9%(9/101),HCVAb 占25。7%(26/101),HIVAb 占 30。7%(31/101),抗TP 占34。7%(35/101),申请HBsAg原因最少;归队检测合格者31人,合格率为30。7%。归队合格献血者中,21人再次献血,献血次数46人次,献血量13 300 ml。结论 血液筛查反应性献血者归队策略有一定比例的允许归队者,防止了合格献血者流失,维护了献血者权益,但需继续加强归队宣传。
Analysis of reentry of blood donors with the reactivity on blood screening in Yunfu City
Objective To analyze the reentry situation of blood donors with the reactivity on blood screening in Yunfu City,so as to provide a basis for continuous improvement of blood donor reentry management.Methods Blood donors with the single-reagent reactivity on hepatitis B surface antigen(HBsAg)and hepatitis C virus antibody(HCVAb),who had completed the shielding period for 6 months,or blood donors with the single-reagent reactivity on human immunodeficiency virus antibody(HIVAb)and treponema pallidum antibody(anti-TP),who had completed the shielding period for 3 months,voluntarily applied to the shielding unit for reentry.After sampling,the shielding unit conducted two dual-reagent enzyme-linked immunosorbent assays(ELISA),and individual nucleic acid tests.They were allowed for reentry after passing the tests.Results From January 2018 to December 2022,a total of 101 blood donors met the criteria for reentry.According to the reasons for applying for reentry,HBsAg accounted for 8.9%(9/101),HCVAb accounted for 25.7%(26/101),HIVAb accounted for 30.7%(31/101),and anti-TP accounted for 34.7%(35/101).The reasons for applying for reentry due to HBsAg were the least.31 people passed the reentry test,with a pass rate of 30.7%.Among the qualified blood donors who reentered,21 people donated blood again,with 46 blood donations and a blood donation volume of 13 300 milliliters.Conclusion The strategy of reentry of blood donors with the reactivity on blood screening allows a certain proportion of reentry of donors,preventing the loss of qualified blood donors and safeguarding the rights and interests of blood donors.However,it is necessary to continue to strengthen the promotion of the reentry of blood donors.

Single-reagent reactivityELISAReentry of blood donorsAnalysis

伍彩发、黄飞、李海强

展开 >

广东省云浮市中心血站,广东云浮 527300

单试剂反应性 ELISA 献血者归队 分析

广东省云浮市医药卫生类科技计划

WS2022031010

2024

中国医药科学
海峡两岸医药卫生交流协会 二十一世纪联合创新(北京)医药科学研究院

中国医药科学

影响因子:1.083
ISSN:2095-0616
年,卷(期):2024.14(6)
  • 17